Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Complementary therapies for depression
RBR-4pgd3ctRecruiting
- Sponsor
- Universidade Federal do Rio Grande do Norte
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of escitalopram in major depressive episode (MDE) and major depressive disorder (MDD) (5 arms), sponsored by Universidade Federal do Rio Grande do Norte. Started Jun 2022; status: recruiting.
02
Drugs
escitalopram
03
Conditions
major depressive episode (MDE)major depressive disorder (MDD)
Beyond the preview
Go deeper on RBR-4pgd3ct.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4pgd3ct.